Status:

RECRUITING

xPedite: A Study to Expedite DIPG and DMG Research

Lead Sponsor:

xCures

Conditions:

Oncology

DIPG

Eligibility:

All Genders

Brief Summary

This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to s...

Detailed Description

xPEDITE is a completely virtual, decentralized, nationwide,real-time, real-world observational study to collect, annotate, standardize, and report the critical data elements of DMG, inclusive of DIPG,...

Eligibility Criteria

Inclusion

  • Diagnosis of diffuse midline glioma according to the WHO 2021 Classification of Tumors of the Central Nervous System diagnostic criteria including diffuse intrinsic pontine glioma (DIPG). In the absence of a pathologically confirmed diagnosis, a grade IV glioma involving the thalamus, hypothalamus, brainstem, cerebellum, midbrain, or spinal cord, or with a pontine epicenter and diffuse involvement of the pons.
  • Patients with any performance status, comorbidity or disease severity are eligible
  • Patients or their legally-authorized representative must be willing and able to provide electronic, informed consent (and assent, if applicable)
  • Informed consent obtained for the XCELSIOR longitudinal outcomes registry (NCT03793088).
  • Patients must be a resident of or receiving care within the United States or US territories.

Exclusion

  • Patient or legally-authorized representative is unable to provide informed consent.
  • Patient or caregiver is unable to complete the PRO and ClinRO by an electronic platform.

Key Trial Info

Start Date :

November 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06140719

Start Date

November 1 2023

End Date

January 1 2027

Last Update

April 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

xCures, Inc.

Los Altos, California, United States, 94022